Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib plus chemotherapy in advanced non-small cell lung cancer
2005-000717-35Phase 3Active
- Sponsor
- Lungmedicinska kliniken
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-small cell lung cancer (NSCLC) comparing Celecoxib plus chemotherapy with Placebo plus chemotherapy (2 arms). Primary endpoint: Overall survival. Started Oct 2005; status: active.
02
Drugs
celecoxib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-000717-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000717-35.